Literature DB >> 2820104

AIDS and germ cell tumors of testis.

A N Tessler, A Catanese.   

Abstract

A retrospective analysis of all testicular tumors treated at our institution over a seven-year period was conducted. Twenty-five of 115 patients were found to have acquired immune deficiency syndrome (AIDS), AIDS-related complexes, or to be at risk for AIDS developing. Non-seminomatous germ cell tumors were more common in the AIDS group.

Entities:  

Mesh：

Year:  1987        PMID： 2820104     DOI： 10.1016/0090-4295(87)90233-0

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  6 in total

1.  Case report: Treatment of metastatic germ cell tumor in a newly diagnosed HIV infected man: use of BEP chemotherapy.

Authors:  Petani Mtonga; Kaweme Mwafulirwa; Raymond Nyirenda; Leo Masamba
Journal:  Malawi Med J       Date:  2011-09       Impact factor: 0.875

2.  Transitional cell carcinoma of the bladder in an HIV-infected patient.

Authors:  H Al Soub
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

Review 3.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

4.  Orchitis: a complication of severe acute respiratory syndrome (SARS).

Authors:  Jian Xu; Lihua Qi; Xiaochun Chi; Jingjing Yang; Xiaohong Wei; Encong Gong; Suatcheng Peh; Jiang Gu
Journal:  Biol Reprod       Date:  2005-10-19       Impact factor: 4.285

5.  Outcome of patients with HIV-related germ cell tumours: a case-control study.

Authors:  T Powles; M Bower; J Shamash; J Stebbing; J Ong; G Daugaard; A De Ruiter; M Johnson; M Fisher; J Anderson; M Nelson; B Gazzard; T Oliver
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

6.  Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?

Authors:  Vassilios Papadopoulos; Lu Li; Mary Samplaski
Journal:  Andrology       Date:  2020-08-05       Impact factor: 4.456
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.